Innovation, structural inspection for new mixed complexes: DNA binding, biomedical applications and molecular docking approaches

References

• Tahlan S, Kumar S, Narasimhan B. Pharmacological significance of heterocyclic 1 H-benzimidazole scaffolds: a review. BMC Chem. 2019;13:,101. doi:10.1186/s13065-019-0516-8
   PubMed Web of Science ®Google Scholar
• Akhtar W, Khan MF, Verma G, et al. Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. Eur J Med Chem. 2017;126:705–753. doi:10.1016/j.ejmech.2016.12.010
   PubMed Web of Science ®Google Scholar
• Karci H, Dündar M, Nawaz Z, et al. Sythesis, characterisation, anticancer and antimicrobial activity of Ag-N-heterocyclic carbene complexes containing benzimidazole derivatives. Inorg Chim Acta. 2024;565:121992. doi:10.1016/j.ica.2024.121992
   Web of Science ®Google Scholar
• Kharitonova MI, Konstantinova ID, Miroshnikov AI. Benzimidazole nucleosides: antiviral and antitumour activities and methods of synthesis. Russ Chem Rev. 2018;87(11):1111–1138. doi:10.1070/RCR4832
   Web of Science ®Google Scholar
• Abu-Dief AM, El-Khatib RM, El-Dabea T, et al. Design, preparation, physicochemical characterization, structural conformational, biological evaluation, and DNA interaction for some new benzimidazole complexes. Appl Organomet Chem. 2024;38:e7358. doi:10.1002/aoc.7358
   Web of Science ®Google Scholar
• Gandin V, Porchia M, Tisato F, et al. Novel mixed-ligand copper (I) complexes: role of diimine ligands on cytotoxicity and genotoxicity. J Med Chem. 2013;56(18):7416–7430. doi:10.1021/jm400965m
   PubMed Web of Science ®Google Scholar
• Abu-Dief AM, El-Dabea T, El-Khatib RM, et al. Synthesize, structural inspection, stoichiometry in solution and DFT calculation of some novel mixed ligand complexes: DNA binding, biomedical applications and molecular docking approach. J Mol Liq. 2024:399:124422. doi:10.1016/j.molliq.2024.124422
   Google Scholar
• Revanasiddappa HD, Shivamallu C, Viswanath PM, et al. Novel benzimidazole derived imine ligand and its Co (III) and Cu (II) complexes as anticancer agents: chemical synthesis, DFT studies, in vitro and in vivo biological investigations. Pharmaceuticals. 2023;16(1):125. doi:10.3390/ph16010125
   Web of Science ®Google Scholar
• Mo Q, Deng J, Liu Y, et al. Mixed-ligand Cu (II) hydrazone complexes designed to enhance anticancer activity. Eur J Med Chem. 2018;156:368–380. doi:10.1016/j.ejmech.2018.07.022
   PubMed Web of Science ®Google Scholar
• Mjos KD, Orvig C. Metallodrugs in medicinal inorganic chemistry. Chem Rev. 2014;114(8):4540–4563. doi:10.1021/cr400460s
   PubMed Web of Science ®Google Scholar
• Muhammad N, Guo Z. Metal-based anticancer chemotherapeutic agents. Curr Opin Chem Biol. 2014;19:144–153. doi:10.1016/j.cbpa.2014.02.003
   PubMed Web of Science ®Google Scholar
• Nazarov AA, Hartinger CG, Dyson PJ. Opening the lid on piano-stool complexes: an account of ruthenium (II)–arene complexes with medicinal applications. J Organomet Chem. 2014;751:251–260. doi:10.1016/j.jorganchem.2013.09.016
   Web of Science ®Google Scholar
• Charef N, Sebti F, Arrar L, et al. Synthesis, characterization, X-ray structures, and biological activity of some metal complexes of the Schiff base 2, 2′-(((azanediylbis (propane-3, 1-diyl)) bis (azanylylidene)) bis (methanylylidene)) diphenol. Polyhedron. 2015;85:450–456. doi:10.1016/j.poly.2014.09.006
   Web of Science ®Google Scholar
• Wehbe M, Leung AW, Abrams MJ, et al. A perspective–can copper complexes be developed as a novel class of therapeutics. Dalton Trans. 2017;46(33):10758–10773. doi:10.1039/C7DT01955F
   PubMed Web of Science ®Google Scholar
• Claudel M, Schwarte JV, Fromm KM. New antimicrobial strategies based on metal complexes. Chemistry. 2020;2(4):849–899. doi:10.3390/chemistry2040056
   Google Scholar
• Hrioua A, Loudiki A, Farahi A, et al. Complexation of amoxicillin by transition metals: physico-chemical and antibacterial activity evaluation. Bioelectrochem. 2021;142:107936. doi:10.1016/j.bioelechem.2021.107936
   PubMed Web of Science ®Google Scholar
• Ronconi L, Sadler PJ. Using coordination chemistry to design new medicines. Coord Chem Rev. 2007;251(13–14):1633–1648. doi:10.1016/j.ccr.2006.11.017
   Web of Science ®Google Scholar
• Hossain MS, Zakaria CM, Kudrat-E-Zahan M. Metal complexes as potential antimicrobial agent: a review. Am J Heterocycl Chem. 2018;4(1):1–21. doi:10.11648/j.ajhc.20180401.11
   Google Scholar
• Marzano C, Pellei M, Tisato F, et al. Copper complexes as anticancer agents. Med Chem. 2009;9(2):185–211.
   Web of Science ®Google Scholar
• do Couto Almeida J, Paixão DA, Marzano IM, et al. Copper (II) complexes with β-diketones and N-donor heterocyclic ligands: crystal structure, spectral properties, and cytotoxic activity. Polyhedron. 2015;89:1–8. doi:10.1016/j.poly.2014.12.026
   Web of Science ®Google Scholar
• Ruiz-Azuara L, Bravo-Gomez ME. Copper compounds in cancer chemotherapy. Curr Med Chem. 2010;17(31):3606–3615. doi:10.2174/092986710793213751
   PubMed Web of Science ®Google Scholar
• Tisato F, Marzano C, Porchia M, et al. Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev. 2010;30(4):708–749. doi:10.1002/med.20174
   PubMed Web of Science ®Google Scholar
• Mutlu Gencçkal HM, Erkisa M, Alper P, et al. Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity. J Biol Inorg Chem. 2020;25:161–177. doi:10.1007/s00775-019-01749-z
   PubMed Web of Science ®Google Scholar
• Crans DC, Smee JJ, Gaidamauskas E, et al. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem Rev. 2004;104(2):849–902. doi:10.1021/cr020607t
   PubMed Web of Science ®Google Scholar
• Da Silva JA, da Silva JJF, Pombeiro AJ. Oxovanadium complexes in catalytic oxidations. Coord Chem Rev. 2011;255(19–20):2232–2248. doi:10.1016/j.ccr.2011.05.009
   Web of Science ®Google Scholar
• El-Deen IM, Shoair AF, El-Bindary MA. Synthesis, characterization and biological properties of oxovanadium (IV) complexes. J Mol Struct. 2019;1180:420–437. doi:10.1016/j.molstruc.2018.12.012
   Web of Science ®Google Scholar
• Kumar A, Dixit A, Sahoo S, et al. Crystal structure, DNA crosslinking and photo-induced cytotoxicity of oxovanadium (IV) conjugates of boron-dipyrromethene. J Inorg Biochem. 2020;202:110817. doi:10.1016/j.jinorgbio.2019.110817
   PubMed Web of Science ®Google Scholar
• Korbecki J, Baranowska-Bosiacka I, Gutowska I, et al. Biochemical and medical importance of vanadium compounds. Acta Biochim Pol. 2012;59(2):195. doi:10.18388/abp.2012_2138
   PubMed Web of Science ®Google Scholar
• Adam MSS, Alghanim AS, Abdel-Rahman OS, et al. Diisatin malonyldihydrazone complexes of high valent oxovanadium and oxozirconium ions for bio-chemical effectiveness and catalytic thiophene oxidation. J Mol Liq. 2024;397:124183. doi:10.1016/j.molliq.2024.124183
   Web of Science ®Google Scholar
• Djokić S. Treatment of various surfaces with silver and its compounds for topical wound dressings, catheter and other biomedical applications. ECS Trans. 2008;11(21):1–12. doi:10.1149/1.2928902
   Google Scholar
• Stillman MJ, Presta A, Gui Z, et al. Spectroscopic studies of copper, silver and gold metallo-thioneins. Met Based Drugs. 1994;1(5–6):375–394. doi:10.1155/MBD.1994.375
   PubMedGoogle Scholar
• Shukla S, Mishra AP. Synthesis, structure, and anticancerous properties of silver complexes. J Chem. 2013;2013:527123. doi:10.1155/2013/527123
   Google Scholar
• Abu-Dief AM, El-Khatib RM, El-Dabea T, et al. Fabrication, structural elucidation of some new metal complexes based on N-(1H-Benzoimidazol-2-yl)-guanidine ligand: DNA interaction, pharmaceutical studies and molecular docking approach. J Mol Liq. 2023;386:122353. doi:10.1016/j.molliq.2023.122353
   Web of Science ®Google Scholar
• Al-Resayes SI, Jarad AJ, Al-Zinkee JM, et al. Synthesis, characterization, antimicrobial studies, and molecular docking studies of transition metal complexes formed from a benzothiazole-based azo ligand. BCSE. 2023;37(4):931–944.
   Google Scholar
• Mabrouk M, Hammad SF, Abdelaziz MA, et al. Ligand exchange method for determination of mole ratios of relatively weak metal complexes: a comparative study. Chem Central J. 2018;12:1–7. doi:10.1186/s13065-018-0512-4
   PubMedGoogle Scholar
• Tarai SK, Mandal S, Bhaduri R, et al. Bioactivity, molecular docking and anticancer behavior of pyrrolidine based Pt (II) complexes: their kinetics, DNA and BSA binding study by spectroscopic methods. Spectrochim Acta A Mol Biomol Spectrosc. 2023;287:122059. doi:10.1016/j.saa.2022.122059
   PubMed Web of Science ®Google Scholar
• Gogoi HP, Barman P. Salophen type ONNO donor Schiff base complexes: synthesis, characterization, bioactivity, computational, and molecular docking investigation. Inorganica Chim Acta. 2023;556:121668. doi:10.1016/j.ica.2023.121668
   Web of Science ®Google Scholar
• Bouzerafa B, Aggoun D, Ouennoughi Y, et al. Synthesis, spectral characterization and study of thermal behavior kinetics by thermogravimetric analysis of metal complexes derived from salicylaldehyde and alkylamine. J Mol Struct. 2017;1142:48–57. doi:10.1016/j.molstruc.2017.04.029
   Web of Science ®Google Scholar
• Coats AW, Redfern JP. Kinetic parameters from thermogravimetric data. Nature. 1964;201(4914):68–69. doi:10.1038/201068a0
   Web of Science ®Google Scholar
• Bonaccorso C, Marzo T, La Mendola D. Biological applications of thiocarbohydrazones and their metal complexes: a perspective review. Pharmaceuticals. 2019;13(1):4. doi:10.3390/ph13010004
   Web of Science ®Google Scholar
• Naureen B, Miana GA, Shahid K, et al. Iron (III) and zinc (II) monodentate Schiff base metal complexes: synthesis, characterisation and biological activities. J Mol Struct. 2021;1231:129946. doi:10.1016/j.molstruc.2021.129946
   Web of Science ®Google Scholar
• Mohamed GG, Omar MM, Ibrahim AA. Biological activity studies on metal complexes of novel tridentate Schiff base ligand. Spectroscopic and thermal characterization. Eur J Med Chem. 2009;44(12):4801–4812. doi:10.1016/j.ejmech.2009.07.028
   PubMed Web of Science ®Google Scholar
• Hehre WJ. Ab initio molecular orbital theory. Acc Chem Res. 1976;9(11):399–406. doi:10.1021/ar50107a003
   Web of Science ®Google Scholar
• Castro ED, Jorge F. Accurate universal Gaussian basis set for all atoms of the periodic table. J Chem Phys 1998;108(13):5225–5229.
   Web of Science ®Google Scholar
• Scholz C, Knorr S, Hamacher K, et al. DOCKTITE. A highly versatile step-by-step workflow for covalent docking and virtual screening in the molecular operating environment. J Chem Inf Model. 2015;55(2):398–406. doi:10.1021/ci500681r
   PubMed Web of Science ®Google Scholar
• Milewski S. Glucosamine-6-phosphate synthase – the multi-facets enzyme. Biochim Biophys Acta (BBA) Protein Struct Mol Enzymol. 2002;1597(2):173–192.
   PubMedGoogle Scholar
• Mouilleron S, Badet-Denisot M-A, Golinelli-Pimpaneau B. Ordering of C-terminal loop and glutaminase domains of glucosamine-6-phosphate synthase promotes sugar ring opening and formation of the ammonia channel. J Mol Biol. 2008;377(4):1174–1185. doi:10.1016/j.jmb.2008.01.077
   PubMed Web of Science ®Google Scholar
• Abu-Dief AM, El-Dabea T, El-Khatib R, et al. Fabrication, Physicochemical characterization and theoretical studies of some new mixed ligands complexes based on N-(1H-benzimidazol-2-yl)-guanidine and 1, 10-phenanthroline: DNA interaction, biological applications and molecular docking approach. J Mol Struct. 2024;1310:138328.
   Google Scholar
• Bolduc JA, Nelson KJ, Haynes AC, et al. Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins. J Biol Chem. 2018;293(30):11901–11912. doi:10.1074/jbc.RA117.001690
   PubMed Web of Science ®Google Scholar
• McNutt MC, Kwon HJ, Chen C, et al. Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells. J Biol Chem. 2009;284(16):10561–10570. doi:10.1074/jbc.M808802200
   PubMed Web of Science ®Google Scholar
• Colloc’h N, Gabison L, Monard G, et al. Oxygen pressurized X-ray crystallography: probing the dioxygen binding site in cofactorless urate oxidase and implications for its catalytic mechanism. Biophys J. 2008;95(5):2415–2422. doi:10.1529/biophysj.107.122184
   PubMed Web of Science ®Google Scholar
• Kumar N, Kaushal R, Awasthi P. Non-covalent binding studies of transition metal complexes with DNA: a review. J Mol Struct. 2023;1288:135751. doi:10.1016/j.molstruc.2023.135751
   Web of Science ®Google Scholar
• Nongpiur CGL, Verma AK, Singh RK, et al. Half-sandwich ruthenium (II), rhodium (III) and iridium (III) fluorescent metal complexes containing pyrazoline based ligands: DNA binding, cytotoxicity and antibacterial activities. J Inorg Biochem. 2023;238:112059. doi:10.1016/j.jinorgbio.2022.112059
   PubMed Web of Science ®Google Scholar
• Dorafshan Tabatabai AS, Dehghanian E, Mansouri-Torshizi H, et al. Computational and experimental examinations of new antitumor palladium (II) complex: CT-DNA-/BSA-binding, in-silico prediction, DFT perspective, docking, molecular dynamics simulation and ONIOM. J Biomol Struct Dyn. 2023:1–23. doi:10.1080/07391102.2023.2226715
   PubMed Web of Science ®Google Scholar
• Mahadevi P, Sumathi S. Schiff base metal complexes: synthesis, optoelectronic, biological studies, fabrication of zinc oxide nanoparticles and its photocatalytic activity. Results Chem. 2023;6:101026. doi:10.1016/j.rechem.2023.101026
   Google Scholar
• Izadyar A, Mansouri-Torshizi H, Dehghanian E, et al. Spectroscopy, docking and molecular dynamics studies on the interaction between cis and trans palladium-alanine complexes with calf-thymus DNA and antitumor activities. J Coord Chem. 2023;76(3–4):519–542. doi:10.1080/00958972.2023.2192331
   Web of Science ®Google Scholar
• Ji X, Zhu X, Chen S, et al. Two Cu (II) and Zn (II) complexes derived from 5-(Pyrazol-1-yl) nicotinic acid: crystal structure, DNA binding and anticancer studies. J Solid State Chem. 2022;305:122707. doi:10.1016/j.jssc.2021.122707
   Web of Science ®Google Scholar
• Sumi M, Nevaditha NT, Kumari BS. Synthesis, structural evaluation, antioxidant, DNA cleavage, anticancer activities and molecular docking study of metal complexes of 2-amino thiophene derivative. J Mol Struct. 2023;1272:134091. doi:10.1016/j.molstruc.2022.134091
   Web of Science ®Google Scholar
• Dorafshan Tabatabai AS, Dehghanian E, Mansouri-Torshizi H. In-silico and in-detail experimental interaction studies of new antitumor Zn (II) complex with CT-DNA and serum albumin. J Biomol Struct Dyn. 2023;41(19):9614–9631. doi:10.1080/07391102.2022.2144459
   PubMed Web of Science ®Google Scholar
• Sarwar T, Ishqi HM, Rehman SU, et al. Caffeic acid binds to the minor groove of calf thymus DNA: a multi-spectroscopic, thermodynamics and molecular modelling study. Int J Biol Macromol. 2017;98:319–328. doi:10.1016/j.ijbiomac.2017.02.014
   PubMed Web of Science ®Google Scholar
• Shahabadi N, Mahdavi M, Taherpour A(A), et al. Synthesis, characterization and in vitro DNA binding studies of a new copper(II) complex containing antioxidant ferulic acid. J Coord Chem. 2017;70(15):2589–2605. doi:10.1080/00958972.2017.1363890
   Web of Science ®Google Scholar
• Bhattacharya S, Sherje AP. Development of resveratrol and green tea sunscreen formulation for combined photoprotective and antioxidant properties. J Drug Delivery Sci Technol. 2020;60:102000. doi:10.1016/j.jddst.2020.102000
   Web of Science ®Google Scholar
• El-Lateef HMA, Khalaf MM, Shehata MR, et al. Fabrication, DFT calculation, and molecular docking of two Fe (III) imine chelates as anti-COVID-19 and pharmaceutical drug candidate. Inter J Mol Sci. 2022;23(7):3994. doi:10.3390/ijms23073994
   PubMed Web of Science ®Google Scholar
• Ejidike IP, Ajibade PA. Synthesis, spectroscopic, antibacterial and free radical scavenging studies of Cu(II), Ni(II), Zn(II) and Co(II) complexes of 4,4’-ethane-1,2- diylbis[nitrilo(1E)eth-1-yl-1-ylidene] dibenzene 1,3-diol Schiff base. J Pharm Sci Res. 2017;9(7):593–600.
   Google Scholar
• Ashrafuzzaman MD, Camellia FK, Mahmud AA, et al. Bioactive mixed ligand metal complexes of Cu (II), Ni (II), and Zn (II) ions: synthesis, characterization, antimicrobial and antioxidant properties. JCCHEMS. 2021;66(3):5295–5299.
   Web of Science ®Google Scholar
• Koleva V, Yotova I, Dragoeva A, et al. Synthesis, cytotoxicity, and promising anticancer potential of novel β-amino- and β-iminophosphonates. J Appl Pharm Sci. 2021;11:080–088.
   Google Scholar
• Parsekar SU, Paliwal K, Haldar P, et al. Synthesis, characterization, crystal structure, DNA and HSA interactions, and anticancer activity of a mononuclear Cu (II) complex with a Schiff base ligand containing a thiadiazoline moiety. ACS Omega. 2022;7(3):2881–2896. doi:10.1021/acsomega.1c05750
   Web of Science ®Google Scholar
• Gavali LV, Mohammed AA, Al-Ogaili MJ, et al. Novel terephthalaldehyde bis (thiosemicarbazone) Schiff base ligand and its transition metal complexes as antibacterial agents: synthesis, characterization and biological investigations. Res Chem. 2024;7:101316.
   Google Scholar
• Roopashree B, Gayathri V, Mukund H. Synthesis, characterization, and biological activities of zinc, cadmium, copper, and nickel complexes containing meta-aminophenyl benzimidazole. J Coord Chem. 2012;65(8):1354–1370. doi:10.1080/00958972.2012.673123
   Web of Science ®Google Scholar
• Nakamoto K. Infrared spectra of inorganic, coordination compounds. Vol. 25. New York: Wiley Interscience; 1970. p. 232–239.
   Google Scholar
• Hassan SS, Khalf-Alla PA. Anti-hepatocellular carcinoma, antioxidant, anti-inflammation and antimicrobial investigation of some novel first and second transition metal complexes. Appl Organometal Chem. 2020;34(4):e5432. doi:10.1002/aoc.5432
   Web of Science ®Google Scholar
• Khan T, Zehra S, Alvi A, et al. Synthesis, characterization, computational studies and antimicrobial activity evaluation of mixed ligand-metal complexes of selected thiosemicarbazones. Chem Select. 2024;9(10):e202400202.
   Google Scholar
• Kumaravel G, Ponnukalai PU, Mahendiran D, et al. Exploring the DNA interactions, FGF growth receptor interaction and biological screening of metal (II) complexes of NNN donor ligand derived from 2–(aminomethyl) benzimidazole. Int J Biol Macromol. 2019;126:1303–1317. doi:10.1016/j.ijbiomac.2018.09.116
   Web of Science ®Google Scholar
• Fataftah MS, Krzyaniak MD, Vlaisavljevich B, et al. Metal–ligand covalency enables room temperature molecular qubit candidates. Chem Sci. 2019;10(27):6707–6714. doi:10.1039/C9SC00074G
   Web of Science ®Google Scholar
• Manjuraj T, Krishnamurthy G, Bodke YD, et al. Synthesis, XRD, thermal, spectroscopic studies and biological evaluation of Co (II), Ni (II) Cu (II) metal complexes derived from 2-benzimidazole. J Mol Struct. 2018;1171:481–487. doi:10.1016/j.molstruc.2018.06.055
   Web of Science ®Google Scholar
• Mabrouk M, Hammad SF, Abdelaziz MA, et al. Ligand exchange method for determination of mole ratios of relatively weak metal complexes: a comparative study. Chem Cent J. 2018;12:1–7. doi:10.1186/s13065-018-0512-4
   Google Scholar
• Eyring H. The activated complex in chemical reactions. J Chem Phys. 1935;3(2):107–115. doi:10.1063/1.1749604
   Google Scholar
• Mansour F, Danielson N. Ligand exchange spectrophotometric method for the determination of mole ratio in metal complexes. Microchem J. 2012;103:74–78. doi:10.1016/j.microc.2012.01.008
   Web of Science ®Google Scholar
• Peng X, Cui GH, Li DJ, et al. Structure, spectroscopy, and theory calculations of mononuclear mixed-ligand copper (II) complex with malonate and 2-propylimidazole [Cu (mal)(PIM)2 (H2O)]. J Mol Struct. 2010;971(1–3):47–52. doi:10.1016/j.molstruc.2010.03.019
   Web of Science ®Google Scholar
• Murugan T, Venkatesh R, Geetha K, et al. Synthesis, spectral investigation, DFT, antibacterial, antifungal and molecular docking studies of Ni (II), Zn (II), Cd (II) complexes of tetradentate Schiff-base ligand. Asian J Chem. 2023;35:1509–1517. doi:10.14233/ajchem.2023.27808
   Google Scholar
• Hay PJ, Wadt WR. Ab initio effective core potentials for molecular calculations. Potentials for the transition metal atoms Sc to Hg. J Chem Phys. 1985;82(1):270–283. doi:10.1063/1.448799
   Web of Science ®Google Scholar
• Shaaban S, Al-Faiyz YS, Alsulaim GM, et al. Synthesis of new organoselenium-based succinanilic and maleanilic derivatives and in silico studies as possible SARS-CoV-2 main protease inhibitors. Inorganics. 2023;11(8):321. doi:10.3390/inorganics11080321
   Web of Science ®Google Scholar
• El-Sherif AA. Synthesis, spectroscopic characterization and biological activity on newly synthesized copper (II) and nickel (II) complexes incorporating bidentate oxygen–nitrogen hydrazone ligands. Inorg Chim Acta. 2009;362(14):4991–5000. doi:10.1016/j.ica.2009.08.004
   Web of Science ®Google Scholar
• Rudrapal M, Gogoi N, Chetia D, et al. Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: molecular docking, MD simulation and drug-likeness/ADMET studies. Saudi J Biolog Sci. 2022;29(4):2432–2446. doi:10.1016/j.sjbs.2021.12.018
   PubMed Web of Science ®Google Scholar
• Yang L, Powell DR, Houser RP. Structural variation in copper (I) complexes with pyridylmethylamide ligands: structural analysis with a new four-coordinate geometry index, τ 4. Dalton Trans. 2007;9:955–964. doi:10.1039/B617136B
   PubMed Web of Science ®Google Scholar
• Alasbahy WM, Shamsi M. In vitro DNA binding, pBR322 cleavage and molecular docking studies of 1, 2-diaminobenzene, dichloro glycyl glycinate tin (IV) and zirconium (IV) complexes. J Biomol Struct Dyn. 2022;40(22):11484–11494. doi:10.1080/07391102.2021.1959402
   PubMed Web of Science ®Google Scholar
• Sanjurani T, Paul S, Barman P. Indole-based NNN donor Schiff base ligand and its complexes: sonication-assisted synthesis, characterization, DNA binding, anti-cancer evaluation and in-vitro biological assay. Bio Organ Chem. 2024;146:107281. doi:10.1016/j.bioorg.2024.107281
   Google Scholar
• Adam MSS, Khalil A. Bioreactivity of divalent bimetallic vanadyl and zinc complexes bis-oxalyldihydrazone ligand against microbial and human cancer series. ctDNA interaction mode. Int J Biol Macromol. 2023;249:125917. doi:10.1016/j.ijbiomac.2023.125917
   Web of Science ®Google Scholar
• Adam MSS, Mohamed MA. Effect of Cu+/2+ ions on the biological activity of their bis-oxalyldihydrazone complexes: ctDNA interaction, antimicrobial and anticancer action. Appl Organomet Chem. 2023;37(9):e7190.
   Web of Science ®Google Scholar
• Khalil MH, Abdullah FO. Synthesis, characterisation, and anticancer and antioxidant activities of novel complexes of palladium and an organic Schiff-base ligand. BCSE. 2024;38(3):605–613.
   Google Scholar
• Khalil A, Adam MSS. Bimetallic bis-aroyldihydrazone-isatin complexes of high O=V (IV) and low Cu (II) valent ions as effective biological reagents for antimicrobial and anticancer assays. Molecules. 2024;29(2):414. doi:10.3390/molecules29020414
   Web of Science ®Google Scholar
• El-Sayed YS, Gaber M, Fahmy RM, et al. Characterization, theoretical computation, DNA-binding, molecular docking, antibacterial, and antioxidant activities of new metal complexes of (E)-1-([1H-1, 2, 4-triazol-3-yl] diazenyl) naphthalen-2-ol. Appl Organomet Chem. 2022;36(5):e6628. doi:10.1002/aoc.6628
   Web of Science ®Google Scholar